WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeStocks › SNDX

Which hedge funds own SNDX? SYNDAX PHARMACEUTICALS INC, Q2 2026 13F holders

Healthcare · Open on the interactive board

6 of the hedge funds tracked by WhaleCreep disclosed a position in SNDX (SYNDAX PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $118.8m in total. The largest holder by portfolio weight is Brevan Howard Capital Management at 0.1% of its book. 4 exited: Farallon Capital Management, Marshall Wace, Point72 Asset Management LP.

6tracked managers holding
0opened this quarter
4exited this quarter

Which hedge funds hold SNDX? Current holders by portfolio weight

ManagerAs ofWeight of bookValueSharesΔ sharesAction
Brevan Howard Capital ManagementQ2 2026 0.1%$6.8m309,065 51% added
Woodline PartnersQ2 2026 0.1%$27.3m1,250,760 0% held
Millennium ManagementQ2 2026 0.0%$44.9m2,053,960 929% added
D. E. Shaw & CoQ2 2026 0.0%$27.1m1,239,954 -23% reduced
Renaissance Technologies LLCQ2 2026 0.0%$7.0m321,600 -35% reduced
Citadel AdvisorsQ2 2026 0.0%$5.6m258,278 -59% reduced

Exited since the previous quarter

ManagerPrior weightPrior value
Farallon Capital Management0.0%$233.6k
Marshall Wace0.0%$1.3m
Point72 Asset Management LP1.0%$46.4m
Tudor Investment0.1%$1.6m

How has hedge fund ownership of SNDX changed?

QuarterManagers holdingCombined value
Q2 20266$118.8m
Q1 202610$152.0m
Q4 20256$144.1m
Q3 20255$103.5m
Q2 20257$53.6m
Q1 20257$101.0m
Q4 20246$85.6m
Q3 20246$147.4m
Q2 20247$166.0m
Q1 20246$149.0m
Q4 20236$184.9m
Q3 20235$75.5m
Q2 20233$98.8m
Q1 20232$92.7m
Q4 20224$175.2m
Q3 20223$153.8m

Counts every tracked manager that disclosed SNDX in that quarter's filing, including managers that have since stopped filing.